{"version":"1.0","provider_name":"Credevo Articles","provider_url":"https:\/\/credevo.com\/articles","author_name":"Feasibility Team","author_url":"https:\/\/credevo.com\/articles\/author\/fteam\/","title":"Ovarian Cancer: Clinical Trial Feasibility | Credevo Articles","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"WqFZNxMKYb\"><a href=\"https:\/\/credevo.com\/articles\/2016\/11\/28\/ovarian-cancer-clinical-trial-feasibility\/\">Ovarian Cancer: Clinical Trial Feasibility<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/credevo.com\/articles\/2016\/11\/28\/ovarian-cancer-clinical-trial-feasibility\/embed\/#?secret=WqFZNxMKYb\" width=\"600\" height=\"338\" title=\"&#8220;Ovarian Cancer: Clinical Trial Feasibility&#8221; &#8212; Credevo Articles\" data-secret=\"WqFZNxMKYb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2016\/11\/Ovarian_cancer_clinical_trial_feasibility_credevo.jpg","thumbnail_width":1920,"thumbnail_height":1080,"description":"With patients with ovarian cancer as the target trial population, clinical trial feasibility was performed. The clinical trial sites\/investigators, who participated in this feasibility came mainly from India, Russia, the Philippines, Vietnam, Thailand,\u00a0and South Korea. What are the causes of ovarian cancer? The causes of ovarian cancer are unclear but doctors have identified factors that [&hellip;]"}